Integrins play important roles in immune response, lymphocyte targeting, and regulation of gene expression. Recently, alpha3 and alpha4 chains of integrins VLA3 and 4 were cloned and sequenced. VLA3 is a fibronectin (FN)/collagen/laminin receptor. VLA4 is a) a FN receptor, b) receptor for vascular cell adhesion molecule-1 (VCAM-1) which is expressed on an activated endothelial cell surface, and c) a homing receptor of lymphocytes for Peyer's patch. VLA5 is a classical FN receptor which recognizes the RGD sequence of a FN cell binding domain. Each integrin plays a role in lymphocyte function, and therefore is a potential diagnostic and therapeutic target in immunologic diseases. To elucidate the mechanism of VLA3-5/ligands interaction, it is proposed 1) to identify the VLA3 binding sites in collagen, laminin and FN molecules by using the recombinant VLA3 expressed in transfected cells and ligand fragments or synthetic peptides, 2) to identify candidate ligand binding sites on VLA3-5 molecules by chemical cross-linking of the labeled synthetic peptides from the identified binding sites in the ligand molecules (e.g. CS-1 peptide for VLA4, RGD containing peptide for VLA5) to integrins, and 3) to examine a) the effects of the mutation of the identified ligand binding sites, b) the effects of the introduction of the function inhibiting mutations in beta2 or beta3 integrin in patients [e.g. Glanzmann's thrombasthenia (Asp 119 to Tyr in beta3 chain)] into the corresponding site of beta1 integrin on the functions of the VLA3-5. In order to accomplish the proposed work the stably transfected CHO cell lines which express a large quantity of recombinant VLA3 or VLA4 species on the surface will be established (VLA5 overproducing cells are already available). These experiments will analyze the common and specific mechanisms of VLA3- 5/ligand interaction. Peptides which modify these interactions might modulate the targeting and function of lymphocytes, monocytes and other cells involved in the pathogenesis of the immunologic diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM047157-05
Application #
2184569
Study Section
Pathobiochemistry Study Section (PBC)
Project Start
1991-07-01
Project End
1996-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Scripps Research Institute
Department
Type
DUNS #
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Mould, A P; Garratt, A N; Puzon-McLaughlin, W et al. (1998) Regulation of integrin function: evidence that bivalent-cation-induced conformational changes lead to the unmasking of ligand-binding sites within integrin alpha5 beta1. Biochem J 331 ( Pt 3):821-8
Mould, A P; Askari, J A; Aota, S i et al. (1997) Defining the topology of integrin alpha5beta1-fibronectin interactions using inhibitory anti-alpha5 and anti-beta1 monoclonal antibodies. Evidence that the synergy sequence of fibronectin is recognized by the amino-terminal repeats of the alpha5 subunit. J Biol Chem 272:17283-92
Meredith Jr, J; Takada, Y; Fornaro, M et al. (1995) Inhibition of cell cycle progression by the alternatively spliced integrin beta 1C. Science 269:1570-2
Kamata, T; Puzon, W; Takada, Y (1994) Identification of putative ligand binding sites within I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) J Biol Chem 269:9659-63
Kamata, T; Takada, Y (1994) Direct binding of collagen to the I domain of integrin alpha 2 beta 1 (VLA-2, CD49b/CD29) in a divalent cation-independent manner. J Biol Chem 269:26006-10
Weitzman, J B; Pasqualini, R; Takada, Y et al. (1993) The function and distinctive regulation of the integrin VLA-3 in cell adhesion, spreading, and homotypic cell aggregation. J Biol Chem 268:8651-7
Takada, Y; Puzon, W (1993) Identification of a regulatory region of integrin beta 1 subunit using activating and inhibiting antibodies. J Biol Chem 268:17597-601
Takada, Y; Ylanne, J; Mandelman, D et al. (1992) A point mutation of integrin beta 1 subunit blocks binding of alpha 5 beta 1 to fibronectin and invasin but not recruitment to adhesion plaques. J Cell Biol 119:913-21
Takada, Y; Murphy, E; Pil, P et al. (1991) Molecular cloning and expression of the cDNA for alpha 3 subunit of human alpha 3 beta 1 (VLA-3), an integrin receptor for fibronectin, laminin, and collagen. J Cell Biol 115:257-66